Pure Global
NCT06239701

Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use - RCT

Butler Hospital·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pregnancy
Drug/Device/Intervention
LPA+Fitbit Intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Butler Hospital
Location
Providence, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 22, 2024
End date
May 30, 2025
Enrollment
50 participants
Primary outcome

Timeline Follow-back (TLFB),Steps/day,Activity Minutes/Day,The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 1,The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 2,The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 3,The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 4,The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 5,The Daily Sessions, Frequency & Quantity of Cannabis Use Inventory - Factor 6,Urine Toxicology Screen,International Physical Activity Questionnaire

Summary

The overall goal of this pilot study is to develop and preliminarily evaluate an LPA
 intervention designed to reduce cannabis use during pregnancy.

ICD-10 classifications
Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06239701
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06239701 through Pure Global AI's free database. This phase not specified trial is sponsored by Butler Hospital and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.